Caplight Directory>Investors>Leerink Partners>Leerink


Leerink Partners

Leerink Partners

Boston, Massachusettsleerink.com

Overview

Leerink Partners is an independent investment bank founded in 1995 with an exclusive focus on the healthcare industry. The firm provides M&A advisory, equity and debt capital markets, equity research, and sales and trading services to companies in the biopharma, digital health, health tech, medical technology, and tools and diagnostics sectors. In addition to its banking services, the firm also engages in investment activities, having co-founded the VC firm Transformation Capital and established the Leerink Transformation Fund. The firm was acquired by SVB Financial Group in 2019 and operated as SVB Leerink and later SVB Securities, before a management buyout in 2023 restored its independence and original name.

Portfolio Companies

26

Investments

CompanyDateStageLead
Kailera TherapeuticsApr 2026IPOLead
Alamar BiosciencesApr 2026IPOCo-investor
Seaport TherapeuticsApr 2026IPOCo-investor
AgomAb TherapeuticsFeb 2026IPOLead
SpyGlassFeb 2026IPOCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.